Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Melioidosis vaccines.

Jonathan Warawa1, Donald E Woods

  • 1Department of Microbiology and Infectious Diseases, University of Calgary Health Sciences Centre, NW, Alberta, Canada. jwarawa@ucalgary.ca

Expert Review of Vaccines
|August 7, 2003
PubMed
Summary

Developing an effective vaccine for melioidosis, a serious bacterial infection caused by Burkholderia pseudomallei, is crucial due to high mortality and common relapses. This review examines current vaccine development strategies to combat this global health threat.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Caspase-11-dependent pyroptosis of lung epithelial cells protects from melioidosis while caspase-1 mediates macrophage pyroptosis and production of IL-18.

PLoS pathogens·2018
Same author

Intubation-mediated intratracheal (IMIT) instillation: a noninvasive, lung-specific delivery system.

Journal of visualized experiments : JoVE·2014
Same author

The stringent response is essential for Pseudomonas aeruginosa virulence in the rat lung agar bead and Drosophila melanogaster feeding models of infection.

Infection and immunity·2011
Same author

Development and application of a cellular, gain-of-signal, bioluminescent reporter screen for inhibitors of type II secretion in Pseudomonas aeruginosa and Burkholderia pseudomallei.

Journal of biomolecular screening·2011
Same author

Burkholderia thailandensis oacA mutants facilitate the expression of Burkholderia mallei-like O polysaccharides.

Infection and immunity·2010
Same author

Identification of Burkholderia mallei and Burkholderia pseudomallei adhesins for human respiratory epithelial cells.

BMC microbiology·2010

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Vaccinology

Background:

  • Melioidosis, caused by Burkholderia pseudomallei, is a significant tropical disease with high mortality rates.
  • The lack of a fully effective antibiotic regimen and frequent relapses necessitate alternative control strategies.
  • Burkholderia pseudomallei poses a potential bioterrorism threat, increasing the urgency for effective countermeasures.

Purpose of the Study:

  • To review the progress and challenges in developing a vaccine against melioidosis.
  • To highlight current research and strategies aimed at creating a viable vaccine for Burkholderia pseudomallei infections.

Main Methods:

  • Literature review of existing research on melioidosis vaccines.
  • Analysis of various vaccine candidates and their developmental stages.
  • Examination of immunological approaches and challenges in vaccine design.

Main Results:

  • Several vaccine candidates targeting Burkholderia pseudomallei have been explored.
  • Different platforms, including subunit and whole-cell vaccines, are under investigation.
  • Significant hurdles remain in achieving robust and long-lasting protective immunity.

Conclusions:

  • Vaccine development for melioidosis is a critical area of research due to the disease's severity and global concern.
  • Continued investigation into novel vaccine strategies and platforms is essential to overcome current limitations.
  • An effective vaccine would significantly improve patient outcomes and public health security against Burkholderia pseudomallei.

Related Experiment Videos